EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
28 hedge funds and large institutions have $25M invested in Eagle Pharmaceuticals, Inc. in 2014 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
28
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3.12M | |
| 2 | +$444K | |
| 3 | +$206K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$176K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$173K |
Top Sellers
| 1 | -$2.27M | |
| 2 | -$1.13M | |
| 3 | -$1M | |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$364K |
| 5 |
Morgan Stanley
New York
|
-$328K |